SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BNB is the native utility token of the BNB Chain ecosystem, acting as a multi-chain asset that powers decentralized applications and facilitates value exchange across its network. It serves as the primary asset for paying transaction gas and smart contract deployment fees while providing users with tiered fee discounts on the Binance exchange. The project’s main value proposition lies in its unified multi-chain architecture, which integrates a smart contract platform, a Layer 2 scaling solution, and a decentralized data storage network into a cohesive settlement and data availability layer.  The network operates on a Proof of Staked Authority consensus mechanism, utilizing a group of 21 active validators known as the Cabinet to verify transactions and produce blocks every 3 seconds. Validators are elected daily based on the amount of BNB staked or delegated to them, and the system employs fast finality and slashing penalties to maintain security and integrity. To manage its long-term economy, the project uses a programmatic dual-burn strategy that permanently removes tokens through real-time fee destruction and quarterly buybacks.  Launched in 2017 by the Binance platform, the project initially distributed 50% of its 200 million token supply to the public, while the founding team received 40% and angel investors were allocated 10%. Though it began as a token on the Ethereum network, it eventually migrated to its own autonomous architecture that remains fully compatible with the Ethereum Virtual Machine. Today, the token's utility includes paying for network gas, participating in staking rewards, and enabling decentralized governance through which holders can vote on technical upgrades and economic changes.

Binance

BNB is currently trending as the community debates its long-term decentralization and exchange utility, while traders closely monitor its price action against technical support levels. Ongoing discussions center on its role in the tokenized stock market and its competitive position against other major blockchain networks.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending due to anticipation surrounding the upcoming July 29th FDA Advisory Committee meeting and the August PDUFA date, with investors closely watching the company's legal battle to regain full U.S. distribution rights. Community discussions remain highly bullish, focusing on the potential for a broad label approval and the strength of the clinical data package supporting deramiocel's efficacy in treating Duchenne muscular dystrophy.

Innodata, Inc. is a data engineering company, which engages in providing artificial intelligence software platforms and management of its services. It operates through the following business segments: Digital Data Solutions (DDS), Synodex, and Agility. The DDS segment combines deep neural networks and human expertise in multiple domains to make unstructured information useable. The Synodex segment enables clients in the insurance and healthcare sectors to transform medical records into useable digital data and to apply technologies to the digital data to augment decision support. The Agility segment provides tools and related professional services that enable public relations and communications professionals to discover influencers, amplify messages, monitor coverage, and measure the impact of campaigns. The company was founded by Todd H. Solomon in 1988 and is headquartered in Ridgefield Park, NJ.

Innodata Inc

Innodata is experiencing intense volatility and profit-taking after hitting new all-time highs, with the community actively debating whether the stock is undergoing a healthy consolidation or if the recent surge has left the valuation vulnerable to a deeper pullback. Traders are closely monitoring the impact of significant insider selling activity alongside broader market fluctuations, while long-term investors remain focused on the company's critical role in the AI data engineering supply chain as a primary catalyst for future growth.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

CorMedix is seeing intense community debate following an earnings report that featured raised guidance and revenue growth alongside delays in key clinical trials, leaving investors divided over the stock's future. While some shareholders are actively celebrating the company's transition to profitability and aggressive share buybacks, others are expressing frustration over stagnant price action and are calling for more transparency from leadership.

Atai Beckley, Inc. is a clinical-stage biopharmaceutical company focused on developing effective, rapid-acting, and convenient mental health treatments. The company is headquartered in New York, NY.

AtaiBeckley Inc.

AtaiBeckley is seeing significant trading activity driven by its upcoming inclusion in the Russell 2000 and 3000 indexes, which has sparked investor excitement regarding potential institutional buying flow. While the community is actively debating the company's long-term pipeline potential and clinical timelines, many are focused on whether this index-driven momentum can sustain price levels as the market digests the news.

TokenOS is the world’s most advanced AI-powered Web3 development platform, designed to turn natural language prompts into fully functional, production-ready blockchain applications. From simple tokens and memecoins to complex DeFi protocols, TokenOS automates the creation, deployment, and auditing of smart contracts and dApps with enterprise-grade reliability. By combining advanced language models with blockchain infrastructure, TokenOS removes the barriers of technical expertise, making Web3 development accessible to everyone. With instant deployment, built-in security best practices, and cross-chain support on the roadmap, TokenOS empowers entrepreneurs, developers, and creators to launch tokenized businesses and decentralized applications in seconds.

TokenOS AI

TokenOS AI is trending as investors react to the project's v4 launch and a revenue-sharing model that rewards node operators and stakers with earnings from its decentralized GPU compute network. The community is focused on the project's low market cap and the high percentage of supply currently locked in staking, which many participants view as a potential catalyst for a supply-side squeeze.

Hedera is a decentralized public network where developers can build secure, fair applications with near real-time consensus. The platform is owned and governed by a council of global innovators including Avery Dennison, Boeing, Deutsche Telekom, DLA Piper, FIS (WorldPay), Google, IBM, LG Electronics, Magalu, Nomura, Swirlds, Tata Communications, University College London (UCL), Wipro, and Zain Group.   The Hedera Consensus Service (HCS) acts as a trust layer for any application or permissioned network and allows for the creation of an immutable and verifiable log of messages. Application messages are submitted to the Hedera network for consensus, given a trusted timestamp, and fairly ordered. Use HCS to track assets across a supply chain, create auditable logs of events in an advertising platform, or even use it as a decentralized ordering service.

Hedera Hashgraph

Hedera Hashgraph is currently attracting significant community attention as investors debate the impact of potential regulatory clarity and its role in future enterprise tokenization, despite ongoing frustrations over price performance and supply dynamics. The discussion is split between those aggressively accumulating on dips, citing strong institutional partnerships and long-term utility, and skeptics who remain critical of the token's historical price action and dilution.

Litecoin is a decentralized, peer-to-peer digital currency designed to enable instant, near-zero cost payments to individuals and merchants worldwide. As an open-source global payment network that functions independently of central banks or intermediaries, its main value proposition lies in providing a scarce digital asset with a fixed maximum supply of 84 million tokens.  The network operates using a Proof of Work mechanism where computers solve complex puzzles to confirm transactions and secure the blockchain. It is distinguished by a block generation time of 2.5 minutes, which allows for faster transaction confirmations and a higher total throughput than earlier protocols. Key technical features include the Scrypt hashing algorithm, which promotes wider network participation, and MimbleWimble Extension Blocks, which improve user privacy by allowing transaction details to be hidden.  The LTC token is used for settling global payments, executing microtransactions through smaller units called litoshis, and diversifying digital portfolios with a highly liquid asset. New tokens are issued to miners as rewards for verifying blocks, though these rewards undergo a halving event approximately every four years to strictly control inflation. This process ensures the ledger maintains immutability, meaning records cannot be changed once they are saved to the global network.  Created by former Google engineer Charlie Lee, the project is supported by the Litecoin Foundation, a non-profit organization dedicated to ecosystem adoption. Unlike many venture-backed projects, it is maintained by a decentralized community of independent developers and a global network of miners. The project has seen recent institutional adoption, with entities like Lite Strategy and Luxxfolio Holdings adding significant amounts of LTC to their corporate treasuries as of late 2025.

Litecoin

Litecoin is trending as retail investors aggressively accumulate and express strong conviction in the asset despite recent volatility and broader market weakness. The community is actively debating the significance of the asset's finite supply and its role in long-term network growth while reacting to technical charts and speculation regarding future regulatory clarity.

Amentum Holdings, Inc. engages in mission-critical, technology-driven services in government and commercial markets. It operates through the Digital Solutions and Global Engineering Solutions segments. The Digital Solutions segment provides advanced digital and data-driven solutions including intelligence analytics, space system development, cybersecurity, and next generation IT. The Global Engineering Solutions segment manages large-scale environmental remediation, nuclear power solutions, platform engineering, sustainment and supply chain management. The company was founded on November 26, 2019 and is headquartered in Chantilly, VA.

Amentum Holdings Inc.

Amentum Holdings is experiencing significant volatility and downward pressure as investors express frustration over consistent intraday sell-offs and a lack of clear catalysts. While some community members remain bullish, citing an extensive government backlog and potential opportunities in nuclear and defense sectors, others are increasingly skeptical due to weak price action and skepticism regarding management's ability to drive growth.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is surging as the community celebrates a breakout past recent highs, fueled by bullish sentiment over positive subcutaneous BRIUMVI clinical data and persistent buyout speculation. Investors are actively discussing a potential short squeeze as the stock continues to display strong institutional accumulation and relative strength against the broader biotech sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Autoscope's Valuation Remains Premium: Is It Worth Overpaying for?

AATC's OptiVu expansion and AI-driven traffic solutions support long-term growth, but premium valuation and margin pressure may limit its near-term appeal.

Top Research Reports for Merck, Southern Company & Lumentum

Merck, Southern Company and Lumentum lead Zacks' featured research reports as growth drivers, expansion plans and key risks shape outlooks.

Autoscope Q1 Earnings Decline Y/Y on Weak Product Sales

AATC's Q1 earnings fall y/y as weak product sales offset steady royalties, while the company continued investing in its OptiVu platform.

Top Analyst Reports for Amazon, Intel & Applied Materials

Amazon drives gains with diverse revenue streams and AI push, but rising costs, debt, and fierce competition cloud its near-term outlook.

Autoscope Q4 Earnings Fall Y/Y Amid Revenue Decline & Transition

AATC reports sharp declines in revenues and earnings as a product transition and inventory adjustments weigh on its Q4 performance.

Top Analyst Reports for Visa, Charles Schwab & Amphenol

Analysts spotlight fresh insights on Visa, Schwab and Amphenol, with new data on growth drivers, risks and market performance.

Autoscope Technologies Posts Q3 Loss, Sharp Y/Y Revenue Drop 

AATC's Q3 results reflect a steep y/y revenue decline, a swing to a loss and transitional challenges as customers shift to the new OptiVu platform.

Revisiting 5 Small Cap AI Stocks: Still Buys?

Mark Zinski, Zacks Small Cap Stock Analyst, returns to review AI stocks from prior podcast episodes.

Autoscope Q2 Earnings Fall 50% Y/Y as Revenues Drop Amid Product Shift

AATC Q2 earnings plunge 50% y/y on lower royalties and sales, but management sees growth ahead with new product adoption and stable cost controls.

The Zacks Analyst Blog Highlights Johnson & Johnson, The Home Depot, Micron Technology, Autoscope Technologies and Nova LifeStyle

JNJ, HD, MU, AATC, and NVFY stand out with strong gains and strategic shifts amid macro headwinds and evolving consumer demand.

Autoscope Technologies Corp. engages in the development of above-ground detection technology, applications, and solutions, offering real-time reaction capabilities and in-depth analytics. It operates through two segments: Intersection & Highway. The company was founded on April 23, 2021 and is headquartered in Minneapolis, MN.

Autoscope Technologies Corporation

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$5.30
Prev Close	$5.27
Open	$5.26
Dividend Yield	10.33%
50-Day Moving Average	$5.45
Beta	0.08
Avg. Volume	7,345.20
PE Ratio	21.48

52-Week High	$7.75
52-Week Low	$5.05
Market Capitalization	$28.5M
EPS (Annual)	$0.2536
Price to Book	2.97
Revenue Per Employee	$300,466.67

Feed

News

Sentiment

Fundamentals

Info

AATCAutoscope Technologies Corporation

Latest AATC News